Oxomemazine
규격
3689-50-7CAS 번호
222-996-8EC 번호
3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amineIUPAC 명칭
C18H22N2O2S화학식
330.4 g/mol분자량
Oxomemazine; 3689-50-7; Dysedon; Doxergan; Imakol; Oxomemazina; Oxomemazinum; Oplex; Exe-top; Trimeprazine 5,5-dioxide; RP 6847; RP-6847; 305MB38V1C; 6487-RP; 6847-RP; DTXSID5023405; PHENOTHIAZINE, 10-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-, 5,5-DIOXIDE; Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide; (+-)-Oxomemazine; RefChem:857801; DTXCID103405; R06AD08; 10-(3-(dimethylamino)-2-methylpropyl)-10H-5lambda6-phenothiazine-5,5-dione; 222-996-8; Dosegran; Oxymemazine; 10-(3-(diMethylaMino)-2-Methylpropyl)-10H-phenothiazine 5,5-dioxide; Alimemazine S,S-dioxide; (+)-Oxomemazine; (-)-Oxomemazine; MFCD00868197; 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; Oxomemazine, (+)-; Oxomemazine, (-)-; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine 5,5-dioxide; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine-5,5-dioxide; Q824SGH3RN; (+/-)-OXOMEMAZINE; 6847 R.P.; 5GP9538P4S; 10H-Phenothiazine-10-propanamine, N,N,.beta.-trimethyl-, 5,5-dioxide; Oxomemazine (INN); OXOMEMAZINE [INN]; 174508-14-6; Oxomemazin; Trimeprazine Sulphone; Oxomemazine; Oxomemazine [INN:DCF]; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide; Oxomemazinum [INN-Latin]; Oxomemazina [INN-Spanish]; EINECS 222-996-8; 174508-13-5; NCGC00182075-03; BRN 0289178; UNII-305MB38V1C; 10-[3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine 5,5-Dioxide; Doxergan (TN); OXOMEMAZINE [MI]; Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine [French]; UNII-Q824SGH3RN; OXOMEMAZINE [MART.]; OXOMEMAZINE [WHO-DD]; 4-27-00-01270 (Beilstein Handbook Reference); MLS006009989; SCHEMBL423634; UNII-5GP9538P4S; orb1298159; CHEMBL2104734; SCHEMBL29378205; CHEBI:135408; ARD14338; Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine; Oxomemazine 1.0 mg/ml in Methanol; AKOS015962134; 6487 RP; 6847 RP; DB13820; NCGC00182075-02; AC-15943; DA-76517; MS-24971; SMR004701064; SY244359; HY-136587; CS-0131898; NS00002586; T9353; D07401; F20164; F816758; SR-01000883964; Q3359071; SR-01000883964-1; 10H-Phenothiazine-10-propanamine, N,N,|A-trimethyl-, 5,5-dioxide; 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (+)-; 10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (-)-; 3-(5,5-Dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethyl-1-propanamine #; 3-(5,5-dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine; 10-[3-(Dimethylamino)-2-methylpropyl]-5lambda~6~-phenothiazine-5,5(10H)-dione; 10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (+)-; 10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (-)-동의어
Oxomemazine 함유 제품
TOPLEXIL 0,33 mg/ml, siropTOPLEXIL 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE ZENTIVA 0,33 mg/ml, siropOXOMEMAZINE ZENTIVA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE VIATRIS 0,33 mg/mL, siropOXOMEMAZINE VIATRIS 0,33 mg/mL SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE UPSA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE TEVA 0,33 mg/ml, siropOXOMEMAZINE TEVA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE SANDOZ CONSEIL 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassiqueOXOMEMAZINE SANDOZ 0,33 mg/ml, siropOXOMEMAZINE SANDOZ 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassique
1/3 페이지
Oxomemazine 판매 기업
CT
Công ty Cổ phần Dược Trung ương MediplantexViet NamCT
Công Ty Cổ Phần Dược Phẩm Tv.Pharm Viet Nam
CT
Công Ty TNHH Wooshin Đồng Nai Viet Nam
CT
Công ty cổ phần dược phẩm Gia NguyễnViet Nam
1/2 페이지